Health Condition 1: N89- Other noninflammatory disorders ofvagina
Conditions
Interventions
Intervention1: Kushta-i-Sadaf: 200 mg twice in a day with water
after meals for 04 weeks (28 days).
Control Intervention1: NIL: NIL
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: All women complaining of excessive white discharge with or without any of the following associated symptoms: 1. Waja al-Zahr (Backache) 2. Naqahat (General Weakness) 3. Burning Micturition 4. Pruritus vulvae
Exclusion criteria
Exclusion criteria: 1. Age below 15 & above 49 years 2. Patient with severe anemia (Hb % Equal or less than 8gm) 3. Known cases of uterine fibroid, prolapse, malignancy and ovarian tumour or cyst 4. Patients on oral contraceptive pills (OCPs)/Intrauterine devices (IUDs)/ Hormonal Replacement Therapy (HRT) 5. Known cases of sexually transmitted diseases 6. Patients on long-term medications for systemic illnesses 7. Any abnormal condition on p/s Examination 8. Patients having acute / acute on chronic/ Chronic PID as per CDC Criteria. 9. Pregnant and Lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of the Habb -e- Leemun in the treatment of Niqris (Chronic Gout) will be carried out on the basis of Pain (VAS-Visual Analogue Scale) and Gout Assessment Questionnaire. Timepoint: At baseline and at the end of treatment. i.e, 0 & 4th week | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological and biochemical investigations for safety assessment i.e., Hemogram,LFT, KFT, Urine Examination: Routine & Microscopic.Timepoint: At baseline and at the end of treatment. i.e, 0 & 4th week | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed